Boston’s biotech hub raises record amounts of money
Updated: Sep 27, 2018
15 biotechnology companies from Massachusetts have entered Nasdaq this year so far.
The leading role of Boston in the area of biotech is well documented. The latest article confirms that this trend continues. According to the MassBio’s 2018 industry snapshot, 48% of all US-based biotech IPOs in 2017 were from Massachusetts, half of which are from the Boston area. To top it all, 2018 has already seen 15 new Massachusetts IPOs entering Nasdaq. To see the complete article and the industry report, visit the link below: